POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT aims to transform precision oncology by combining a portfolio of targeted radioligand assets, a seasoned management team, an industry-leading pipeline, in-house manufacturing capabilities, and secured supply for medical isotopes including actinium-225 and lutetium-177. POINT\xe2\x80\x99s active clinical trials include FRONTIER, a phase 1 trial for PNT2004, a pan-cancer program targeting fibroblast activation protein-\xce\xb1 (FAP-\xce\xb1), and SPLASH, the phase 3 trial for PNT2002 for people with metastatic castration resistant prostate cancer (mCRPC) after second-line hormonal treatment.
TO BE CONSIDERED, APPLICANTS MUST BE LEGALLY ENTITLED TO WORK IN CANADA.
Location of work
The position will be working remotely with the anticipation of travel for team and client meetings. Our business requirements are to work to accommodate Eastern Time Zone. To work in synergy, it is preferred that our applicants can work Eastern Time Zone to accommodate team and client meetings.
Reporting to the Senior Manager, Finance, the Senior Financial Analyst (\xe2\x80\x9cSFA\xe2\x80\x9d) develops, interprets, and implements financial concepts for financial reporting and control. The SFA performs technical analysis to report on financial performance. Gathers, analyzes, prepares, and summarizes financial results for external financial reporting and ad hoc analysis. Performs accounting standard research (under U.S. GAAP), as required, and interprets the guidance for appropriate accounting treatment. This role will also assist in the preparation of journal entries, preparing ad hoc reports and analysis as well as helping maintain several internal databases and systems.
Key Accountabilities
MNCJobz.com will not be responsible for any payment made to a third-party. All Terms of Use are applicable.